EAM Investors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-69,096
Closed -$3.18M 300
2018
Q3
$3.18M Buy
+69,096
New +$3.18M 0.47% 97